Log in Book a Demo

US Pharma & Biotech Cardiology - PPC Market Share Analysis September 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Cardiology – US

Google AI Overview visibility for Pharma & Biotech Cardiology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 81.4675462305
18.5324537695
81%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 18
82
18%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 7%
Navigational 2%
Seasonal 0%
Local 0%
Problem Solving 23%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
repatha.com 62.68
repathahcp.com 18.08
telyrx.com 4.41
goodrx.com 4.22
bmscustomerconnect.com 2.31
leqviohcp.com 1.23
vyndamax.com 1.08
nexlizethcp.com 0.64
leqvio.com 0.61
lipitor.com 0.58
others 4.16
  • repatha.com - 62.68%
  • repathahcp.com - 18.08%
  • telyrx.com - 4.41%
  • goodrx.com - 4.22%
  • bmscustomerconnect.com - 2.31%
  • leqviohcp.com - 1.23%
  • vyndamax.com - 1.08%
  • nexlizethcp.com - 0.64%
  • leqvio.com - 0.61%
  • lipitor.com - 0.58%
  • others - 4.16%

Copyright © Adthena. All rights reserved.

In the PPC landscape, repatha.com dominates with 62.68% click share, followed by repathahcp.com at 18.08%. Goodrx.com and telyrx.com trail behind, while ‘others’ collectively hold 4.16%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date repatha.com repathahcp.com goodrx.com telyrx.com vyndamax.com bmscustomerconnect.com vyndamax.pfizerpro.com nexlizethcp.com leqviohcp.com leqvio.com
2026/09/01 59.09% 30.03% 0.43% 0% 1.68% 0.9% 1.12% 0.14% 0.36% 1.68%
2026/09/02 57.11% 32.32% 0.48% 0% 2.09% 0.56% 1.16% 0.01% 0.39% 0.05%
2026/09/03 54.6% 36.96% 0.32% 0% 1.62% 0.68% 1.17% 0.01% 0.01% 0.03%
2026/09/04 58.28% 28.98% 0.89% 3.5% 2.06% 0.63% 1.34% 0.01% 0% 0.02%
2026/09/05 56.87% 30.76% 0.5% 1.65% 1.42% 0.43% 0.96% 0.58% 0.69% 1.33%
2026/09/06 58.31% 28.67% 0.51% 2.24% 0.87% 0.88% 0.89% 0.81% 2.26% 1.01%
2026/09/07 52.97% 32.03% 0.84% 2.34% 1.89% 1.25% 1.13% 0.44% 0.94% 0.83%
2026/09/08 55.6% 26.21% 1.03% 2.67% 2.55% 1.2% 1.47% 0.75% 1.9% 0.69%
2026/09/09 58.13% 28.81% 0.84% 1.49% 1.97% 1% 0.95% 0.3% 0.55% 0.31%
2026/09/10 56.97% 29.39% 0.61% 0.14% 2.24% 1.23% 1.12% 0.53% 0.59% 1.59%
2026/09/11 56.03% 28.41% 2.13% 0.65% 1.84% 1.07% 0.91% 0.58% 0.8% 1.05%
2026/09/12 53.26% 26.61% 6.18% 2.37% 0.86% 0.73% 0.51% 0.94% 2.3% 0.3%
2026/09/13 57.13% 26.49% 4.51% 1.19% 1.03% 0.52% 0.62% 0.88% 2.34% 0.38%
2026/09/14 60.28% 24.02% 3.31% 2.15% 1.04% 0.88% 0.71% 0.72% 1.79% 0.1%
2026/09/15 61.33% 25.65% 2.06% 1.83% 1.09% 0.71% 0.68% 0.8% 0.67% 0.14%
2026/09/16 61.34% 25.53% 2.11% 2.99% 1.45% 0.51% 1.03% 0.69% 0.86% 0.48%
2026/09/17 55.6% 26.6% 2.16% 6.07% 1.49% 0.73% 0.81% 0.79% 0.97% 0.23%
2026/09/18 56.62% 26.62% 1.25% 1.56% 1.6% 0.89% 0.86% 1.18% 2.06% 0.32%
2026/09/19 60.86% 22.99% 1.83% 3.38% 1.15% 0.68% 0.79% 0.98% 0.95% 0.05%
2026/09/20 60.82% 25.2% 1.59% 3.84% 0.76% 0.73% 0.8% 0.65% 1.3% 0.07%
2026/09/21 55.67% 25.38% 5.98% 4.23% 1.14% 0.43% 0.86% 0.74% 1.64% 0.23%
2026/09/22 57.57% 26.26% 4.19% 3.11% 1.29% 0.5% 0.67% 0.8% 1.29% 0.68%
2026/09/23 62.17% 25.86% 2.02% 2.14% 1.24% 0.57% 0.76% 0.73% 1.19% 0.6%
2026/09/24 59.08% 22.21% 4.43% 5.45% 1.17% 0.46% 0.66% 0.73% 1.44% 0.34%
2026/09/25 60.57% 17.54% 5.27% 4.22% 1.01% 0.68% 0.62% 0.85% 2.01% 2.96%
2026/09/26 59.13% 23.25% 3.43% 3.27% 0.92% 0.47% 0.45% 0.83% 3.55% 1.99%
2026/09/27 53.73% 22.65% 2.82% 10.94% 0.87% 0.76% 0.46% 0.72% 3.62% 0.72%
2026/09/28 64.06% 19.23% 2.75% 1.48% 1.24% 0.95% 0.76% 0.36% 3.63% 0.94%
2026/09/29 57.24% 27.02% 3.01% 3.04% 1.52% 0.99% 0.89% 0.48% 0.98% 0.45%
2026/09/30 41.33% 36.46% 6.98% 2.48% 1.56% 1.25% 1.08% 1.05% 1.01% 0.36%
  • repatha.com
  • repathahcp.com
  • goodrx.com
  • telyrx.com
  • vyndamax.com
  • bmscustomerconnect.com
  • vyndamax.pfizerpro.com
  • nexlizethcp.com
  • leqviohcp.com
  • leqvio.com

Copyright © Adthena. All rights reserved.

In September 2026, repatha.com led with fluctuating spend, peaking mid-month. Repathahcp.com saw a decline, while goodrx.com surged late. Telyrx.com spiked on the 27th. Vyndamax.com remained steady. The month ended with repatha.com dropping significantly.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/09/01 34
2026/09/02 32
2026/09/03 31
2026/09/04 33
2026/09/05 36
2026/09/06 36
2026/09/07 38
2026/09/08 35
2026/09/09 40
2026/09/10 40
2026/09/11 39
2026/09/12 51
2026/09/13 39
2026/09/14 40
2026/09/15 38
2026/09/16 40
2026/09/17 45
2026/09/18 41
2026/09/19 43
2026/09/20 42
2026/09/21 41
2026/09/22 41
2026/09/23 42
2026/09/24 42
2026/09/25 43
2026/09/26 42
2026/09/27 43
2026/09/28 43
2026/09/29 40
2026/09/30 41

Copyright © Adthena. All rights reserved.

September saw a dynamic shift in distinct advertisers, starting at 34 and peaking at 51 mid-month. The month concluded with a stable 41, reflecting a competitive landscape.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
telyrx.com 3.21%
goodrx.com 2.31%
leqviohcp.com 0.48%
familyheart.org 0.39%
leqvio.com 0.36%
vyndamax.com -0.18%
pennmedicine.org -0.25%
bmscustomerconnect.com -0.43%
repathahcp.com -1.48%
repatha.com -4.37%

Copyright © Adthena. All rights reserved.

Telyrx.com surged with a 3.21% click share increase, while repatha.com faced a 4.37% decline. Goodrx.com also rose by 2.31%.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date repathahcp.com repatha.com telyrx.com goodrx.com nexlizethcp.com leqviohcp.com bmscustomerconnect.com tryngolzahcp.com amvuttra.com leqvio.com
2026/09/01 47.59% 34.28% 0% 0.45% 0.3% 0.56% 1.73% 1.08% 2.07% 1.64%
2026/09/02 47.1% 33.86% 0% 0.41% 0.01% 1.26% 1.23% 1.48% 2.82% 0.11%
2026/09/03 54.3% 30.46% 0% 0.33% 0.01% 0.03% 1.53% 1.36% 2.95% 0.05%
2026/09/04 42.46% 35% 8.1% 0.77% 0.02% 0% 1.41% 1.89% 1.87% 0.03%
2026/09/05 44.33% 33.3% 4.22% 0.56% 1.09% 1.47% 0.97% 1.72% 1.76% 1.31%
2026/09/06 43.74% 34.77% 5.9% 0.43% 1.58% 2.44% 1.37% 0.94% 1.3% 1%
2026/09/07 45.24% 28.92% 5.8% 0.74% 0.88% 1.88% 1.96% 1.47% 2.2% 0.7%
2026/09/08 39.8% 30.1% 7.31% 0.85% 1.58% 2.09% 2% 1.62% 2.63% 0.67%
2026/09/09 43.44% 33.5% 3.86% 0.68% 0.55% 0.97% 1.62% 1.38% 2.1% 0.24%
2026/09/10 44.4% 33.2% 0.55% 0.58% 1% 1.29% 1.92% 2.12% 1.82% 1.7%
2026/09/11 41.11% 31.84% 1.21% 3.22% 0.96% 1.89% 1.64% 2.3% 1.58% 0.84%
2026/09/12 37.47% 26.32% 7.62% 8.16% 1.83% 3.74% 1.14% 0.91% 1.17% 0.28%
2026/09/13 40.11% 30.38% 2.91% 7.21% 1.81% 4.71% 1.05% 1.37% 1.44% 0.57%
2026/09/14 38.25% 31.8% 6.25% 3.49% 1.47% 4.12% 1.33% 1.29% 1.32% 0.16%
2026/09/15 36.89% 31.46% 11.04% 2.15% 1.55% 1.27% 1.01% 0.79% 1.45% 0.19%
2026/09/16 36.97% 34.2% 12.27% 3.25% 1.24% 1.67% 0.94% 0.18% 1.17% 1.06%
2026/09/17 38.39% 30.1% 13.17% 2.47% 1.55% 1.85% 1.19% 1.48% 1.3% 0.4%
2026/09/18 37.32% 31.65% 4.2% 1.74% 2.27% 3.49% 1.22% 0.99% 0.93% 0.66%
2026/09/19 33.99% 32.56% 9.83% 2.83% 1.97% 1.7% 1.06% 1.18% 0.9% 0.09%
2026/09/20 37.3% 31.87% 12.41% 2.65% 1.34% 2.64% 1.15% 1.95% 0.65% 0.14%
2026/09/21 34.33% 27.46% 15.62% 9.63% 1.36% 2.8% 0.73% 0.7% 0.78% 0.39%
2026/09/22 37.08% 29.29% 9.97% 7.39% 1.5% 2.12% 0.75% 0.64% 0.98% 3.11%
2026/09/23 41.4% 34.36% 7.72% 2.97% 1.61% 2.36% 1.09% 0.84% 0.83% 1.19%
2026/09/24 29.4% 26.69% 24.23% 7.3% 1.28% 2.78% 0.7% 0.35% 0.51% 0.35%
2026/09/25 24.38% 28.63% 17.44% 8.43% 1.54% 3.52% 0.98% 1.13% 0.79% 6.37%
2026/09/26 34.4% 30.53% 12.02% 5.56% 1.56% 5.09% 0.81% 0.46% 0.87% 4.06%
2026/09/27 29.87% 23.41% 27.18% 4.65% 1.36% 5.72% 1.01% 0.28% 0.79% 1.03%
2026/09/28 29.67% 35.99% 8.37% 5.5% 0.88% 5.87% 1.63% 1.08% 1.6% 1.84%
2026/09/29 39.94% 28.4% 13.72% 2.63% 0.97% 1.7% 1.41% 1.03% 1.37% 0.94%
2026/09/30 42.21% 18.11% 10.05% 9.53% 1.65% 1.56% 1.55% 1.4% 0.81% 0.46%
  • repathahcp.com
  • repatha.com
  • telyrx.com
  • goodrx.com
  • nexlizethcp.com
  • leqviohcp.com
  • bmscustomerconnect.com
  • tryngolzahcp.com
  • amvuttra.com
  • leqvio.com

Copyright © Adthena. All rights reserved.

In September 2026, repathahcp.com led with fluctuating impressions, peaking early and stabilizing at 42.21. Repatha.com saw a decline, ending at 18.11. Telyrx.com surged mid-month, closing at 10.05. Goodrx.com and leqviohcp.com showed varied trends, finishing at 9.53 and 1.56, respectively.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology - Last month
  1. 1
    Rosuvastatin 2026 Prices, Coupons & Savings Tips - GoodRx https://www.goodrx.com/

    Use GoodRx® to save up to 80%. Getting your medication should never be a financial burden. We help you get the...

  2. 2
    Side Effects & Results - Results & Safety Prescription treatment website

    Not Meeting Your LDL-C Treatment Goal? Talk To Your Doctor About A Treatment Option.

  3. 3
    Repatha® (evolocumab) - What Is Repatha®? https://www.repatha.com/

    See if Repatha Is The Right Treatment For You. Learn More On The Official Patient Site.

  4. 4
    Repatha® (evolocumab) - Dosing & Administration https://www.repathahcp.com/

    Learn More About Repatha by Visiting the Official Product Website for Physicians. Watch Videos & Discover Insights from Healthcare Professionals...

  5. 5
    Learn what rosuvastatin is https://www.telyrx.com/

    Learn what rosuvastatin is, how it works, common side effects, and how to get it prescribed and delivered online through TelyRx.com.

Copyright © Adthena. All rights reserved.

In the competitive landscape of cardiology PPC ads, GoodRx stands out by emphasizing affordability, offering savings up to 80%. Leqvio and Repatha focus on treatment efficacy and safety, targeting patients and healthcare professionals. TelyRx highlights convenience in obtaining rosuvastatin online.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.